ResearcherTottori UniversityNo recent work listed

Kazushi Hara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9724-3628; OpenAlex author ID A5103046636. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 1 paper

Papers 1

TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer. Co-author DOI 10.1016/j.tranon.2022.101608 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Teppei Sunaguchi · 1 shared paper, 2023 · strength 0.17
- Paper TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer. DOI 10.1016/j.tranon.2022.101608 ↗
Masaki Morimoto · 1 shared paper, 2023 · strength 0.17
- Paper TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer. DOI 10.1016/j.tranon.2022.101608 ↗
Yoshiyuki Fujiwara · 1 shared paper, 2023 · strength 0.17
- Paper TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer. DOI 10.1016/j.tranon.2022.101608 ↗
Takehiko Hanaki · 1 shared paper, 2023 · strength 0.17
- Paper TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer. DOI 10.1016/j.tranon.2022.101608 ↗
Teruhisa Sakamoto · 1 shared paper, 2023 · strength 0.17
- Paper TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer. DOI 10.1016/j.tranon.2022.101608 ↗
Tatsuya Matsura · 1 shared paper, 2023 · strength 0.17
- Paper TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer. DOI 10.1016/j.tranon.2022.101608 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.